Skip to main content

February 2025

Opportunity for Pharma or Biotech or Life sciences candidates to work on male contraceptives at MAHE

ICMR Extramural project titled Study on the Pharmacological Inhibition of Human Sperm GSK3a and Calcineurin on Fertilization Parameters to Develop Male Contraceptives at the Manipal Centre for Biotherapeutics Research. M.Sc. Biotechnology / Biochemistry / Microbiology / Molecular Biology/Genome Engineering/ Medical Biotechnology/ Biomedical Science / Life Science,  M.Tech. Biotechnology / Biomedical Engineering,  M.Pharm
Life sciences recruitment as Project Research Scientist for Acute Lymphoblastic Leukemia research at AIIMS
Delineating and characterizing the m6A RNA methylation marks in primary and relapsed B-cell Acute Lymphoblastic Leukemia; MSc Life Sciences research experience or PhD in life sciences; Hands on research experience in molecular biology experiments PCR, Real Time PCR, Cloning, bioinformatics analysis of transcriptomes, exomes, custom analysis is desirable.
Advertisement for post of Project Research Scientist 1 Non-Medical at ILBS - Salary 71k pm
A multi-omics approach to delineate the role of neutrophil and plasma indicators in the progression of sepsis and predisposition to early mortality in Severe Alcoholic Hepatitis, SAH Patients. First class post graduate degree including integrated PG degrees
Applications are invited for the post of Secretary of the National Commission for Allied and Healthcare Professions, MOHFW
A post graduate degree in any discipline, preferably related to Medical or Allied and Healthcare education or healthcare policy or health administration or public health from any University with outstanding ability and proven administrative capacity and integrity.
Recruitment of Clinical Research Coordinator at Department of Pulmonary, Critical Care and Sleep Medicine, AIIMS
A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
TCS hiring Pharma candidates for Gandhinagar location, only experienced
Looking for clinical Database Developer experience in eCRF build and edit checks build in Veeva studio; Create eCRF specifications, design, develop and unit test and functionally validate clinical trial setup process. Providing support for the mapping and transformation of clinical data to CDISC SDTM standards. Work independently and accountable for study Data Management deliverables; Coordinate with Biostatistician, Clinical, Medical and local study team as applicable
Torrent Pharmaceuticals hiring for a Product Management Team
Responsible for designing overall marketing and communication strategy of brands; Good at Sales & Market data analysis; Must possess knowledge of product strategy, product launch. Torrent Pharmaceuticals announces hiring for a Product Management Team; B.Sc. /B.Pharma plus MBA
Walk in for Production, QC, Warehouse in OSD Formulations at Granules India
B.sc/ B.Pharm/ M.Pharm/ M.Sc; Instrument Analysis HPLC, GC, LCMs, GCMs / Microbiology Testing. Production, QC, Warehouse OSD Formulations
Job as Executive - Formulation Analytical Research & Development at MSN Group
M.Pharmacy / M.Sc. / BPharm; Undertake method development, troubleshooting and method validation to GMP and ICH. Investigation of non-conforming samples, CAPAs, data evaluation and reporting. Write cGMP Quality documents including Standard Operating Procedures, laboratory equipment procedures and investigational protocols.
Nemluvio of Gladerma granted marketing authorization in the United Kingdom and Switzerland
Galderma today announced that the United Kingdom (UK) Medicines and Healthcare products Regulatory Agency and Swissmedic have granted the marketing authorization of nemolizumab for the treatment of both atopic dermatitis and prurigo nodularis in the UK and Switzerland, respectively. Specifically, the approvals are for nemolizumabs subcutaneous use for the treatment of moderate-to-severe atopic dermatitis in combination with topical corticosteroids and/or calcineurin inhibitors